These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8171712)

  • 41. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 42. Hyperlipoproteinemia in renal transplant recipients: is there a linkage with chronic vascular rejection?
    Dimény E; Fellström B; Larsson E; Tufveson G; Lithell H
    Transplant Proc; 1993 Apr; 25(2):2065-6. PubMed ID: 8470272
    [No Abstract]   [Full Text] [Related]  

  • 43. Can a diagnosis of renal allograft rejection be based on histology alone?
    Midtvedt K; Hartmann A; Sund S
    Clin Transplant; 1998 Aug; 12(4):300-2. PubMed ID: 9686323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive value of Banff score of early kidney allograft biopsies for 1-year graft survival.
    Kaminska D; Bernat B; Mazanowska O; Krasnowski R; Polak W; Patrzalek D; Kochman A; Klinger M
    Transplant Proc; 2006; 38(1):59-61. PubMed ID: 16504664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201-995.
    Schuurman HJ; Beckmann N; Briner U; Bruns C; Bruttel K; Tanner M; Tolcsvai L; Weckbecker G
    Transplant Proc; 1996 Dec; 28(6):3272-5. PubMed ID: 8962271
    [No Abstract]   [Full Text] [Related]  

  • 46. Peritubular capillaritis in early renal allograft is associated with the development of chronic rejection and chronic allograft nephropathy.
    Aita K; Yamaguchi Y; Horita S; Ohno M; Tanabe K; Fuchinoue S; Teraoka S; Toma H
    Clin Transplant; 2005; 19 Suppl 14():20-6. PubMed ID: 15955165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of 214 percutaneous renal allograft biopsies.
    Kim HC; Park SB; Lee SH; Cho WH; Park CH; Park KK
    Transplant Proc; 1994 Aug; 26(4):1997-8. PubMed ID: 8066648
    [No Abstract]   [Full Text] [Related]  

  • 48. The renal medulla in acute renal allograft rejection: comparison with renal cortex.
    Wang H; Nanra RS; Carney SL; Gillies AH; Hibberd AD; Jones BF; Murugasu R; Price A; Trevillian PR
    Nephrol Dial Transplant; 1995; 10(8):1428-31. PubMed ID: 8538937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic allograft rejection: an update.
    Häyry P; Yilmaz S
    Transplant Proc; 1994 Dec; 26(6):3159-60. PubMed ID: 7998102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of cyclosporine dose on renal allograft function in an Asian population.
    Vathsala A; Lee WT; Lim CH
    Transplant Proc; 1994 Oct; 26(5):2507-8. PubMed ID: 7940768
    [No Abstract]   [Full Text] [Related]  

  • 51. Should patients with renal allograft loss due to noncompliance be retransplanted?
    Troppmann C; Benedetti E; Gruessner RW; Najarian JS; Matas AJ
    Transplant Proc; 1995 Feb; 27(1):1093. PubMed ID: 7878818
    [No Abstract]   [Full Text] [Related]  

  • 52. Size matters in renal allograft survival.
    Shapiro R
    J Am Soc Nephrol; 2010 Jun; 21(6):890-1. PubMed ID: 20488950
    [No Abstract]   [Full Text] [Related]  

  • 53. Single center experience with renal allograft sharing.
    Cacciarelli T; Sumrani N; Delaney V; DiBenedetto A; Hong JH; Sommer BG
    Transplant Proc; 1991 Oct; 23(5):2672-3. PubMed ID: 1926528
    [No Abstract]   [Full Text] [Related]  

  • 54. Nonimmune factors may contribute to chronic rejection of kidney transplants.
    Azuma H; Tullius SG; Heemann UW; Tilney NL
    Transplant Proc; 1994 Aug; 26(4):2109-10. PubMed ID: 8066686
    [No Abstract]   [Full Text] [Related]  

  • 55. Analysis of macrophage subsets in renal allograft biopsies with new monoclonal antibodies.
    Burkhardt K; Sorg C; Andreesen R; Mues B; Hammer C; Land W; Gurland HJ
    Transplant Proc; 1990 Aug; 22(4):1844-5. PubMed ID: 2389457
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma soluble interleukin-2 receptor (IL-2RS) level and activation markers in blood in the follow-up of renal allograft patients.
    Malcus C; Pouteil-Noble C; Touraine F; Raffaele P; Touraine JL
    Transplant Proc; 1990 Aug; 22(4):1865-6. PubMed ID: 2389463
    [No Abstract]   [Full Text] [Related]  

  • 57. A second native renal allograft of donor origin in a model of chronic rejection demonstrates improved long-term function.
    Tullius SG; Nieminen M; Bechstein WO; Jonas S; Steinmüller T; Pratschke J; Zeilinger K; Graser E; Volk HD; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):3029. PubMed ID: 9365655
    [No Abstract]   [Full Text] [Related]  

  • 58. Can chronic vascular rejection of a renal transplant be predicted?
    Dimény E; Fellström B; Larsson E; Lithell H; Wahlberg J
    Transplant Proc; 1995 Feb; 27(1):881-3. PubMed ID: 7879218
    [No Abstract]   [Full Text] [Related]  

  • 59. Outcome of kidney function in pediatric transplantation.
    Lubrano R; Trapasso E; Brenna S; Castello MA; Pretagostini R; Alfani D; Poli L; Berloco P; Cortesini R
    Transplant Proc; 1994 Feb; 26(1):52-3. PubMed ID: 8109019
    [No Abstract]   [Full Text] [Related]  

  • 60. Intragraft Toll-like receptor profiling in acute renal allograft rejection.
    Dessing MC; Bemelman FJ; Claessen N; Ten Berge IJ; Florquin S; Leemans JC
    Nephrol Dial Transplant; 2010 Dec; 25(12):4087-92. PubMed ID: 20876367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.